成功案例:印度生物化学与纳米技术领域无业研究者EB-1A申请9天顺利通过!
客户感言:
「感谢你们帮助我递交I-140。真心感激你们的帮助。」
於2013年10月15日,北美联合律师事务所收到了一位生物化学与纳米技术领域无业研究者EB-1A的申请顺利获准通知!(批准通知)
领域:生物化学与纳米技术
受益人递交申请时的职位:无业研究者
受益人国籍:印度
服务中心:德州服务中心(TSC)
递交申请时所在地:乔治亚州
批准通知日期:2013年11月15日
处理时间:9天(加急申请)
案例总结:
这次北美联合律师事务所有幸合作的客户是一位来自生物化学与纳米技术领域的研究员。递交申请之时,她处于失业状态。她在博士与博士后研究期间的主要工作是开发与利用生物传感器与金属纳米团簇来检测和诊断疾病。很明显,该课题对公共健康与纳米科学的发展具有深远影响。
为证实其研究贡献,我们出具了大量文件资料列举该客户的成就。就学术研究来说,本客户著有研究专利一项,在其领域一流期刊发表学术论文11篇、评论文章10篇以及国际国内重要学术会刊文献6篇。在递交申请之前,该客户获得了来自国内外专家学者至少442次学术引用。此外,多家主流学术期刊还邀请该客户担任评审,为不同期刊审阅文稿17篇之多。这些一项项成就都客观真实地展示了该客户在其领域的杰出能力与巨大潜力。
与此同时,我们还利用推荐信,从另一个侧面通过推荐人之口证实客户的卓越成就。在提到该受益人的突出成就时,一位独立推荐人总结指出 “Although I do not know her personally, I witnessed this presentation and it thoroughly impressed me. [She] was responsible for the conception and creation of electrodes that had the ability to detect uric acid in solution. The electrodes were able to achieve detection by arranging themselves into a monolayer covered the ITO glass electrodes. This technology is coveted by physicians and professionals in the healthcare industry. There are varieties of life-threatening and life-changing conditions that can be treated, but often only if they are detected in their early stages. Some of these conditions include chronic kidney disease, leukemia, gout, and pneumonia. The trait that links these diseases is the presence of uric acid (UA), or urate, in the body. Urate can be found in blood serum and urine, and is the primary end-product of purine metabolism. Detectors that can pick up on the presence of urate can help physicians halt the progression of these diseases, which translates to a large impact on quality of life, survival rates, and quality of care for the countless victims of these diseases, which rank amongst some of the most prevalent in our world.”
凭借大量的文件资料,北美联合律师事务所表示:此申请人完全符合杰出人才类别移民的要求。最终,凭借我们帮助客户准备的充足证据与强有力的论述,该案客户的EB1A申请仅仅在9天后就顺利通过了。

